Home / ORCHPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ORCHPHARMA.NS make money? Does ORCHPHARMA.NS have pricing power? What's the Earnings Whisper? Will ORCHPHARMA.NS profit more as the business scales? What is ORCHPHARMA.NS's management track record? Is ORCHPHARMA.NS's current price justified?

Orchid Pharma Limited

₹911.25 +$118.10 (+14.89%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹928.05

Day Range

₹896₹938.95

Year Range

₹480₹1143.5

Market Cap

46.22B

AVG Volume

168.66K

Trailing/Forward PE

532.89/21.49

PEG ratio

1.33

Dividend Yield

Next Earnings Date

2026-11-16

Primary Exchange

National Stock Exchange of India

Revenue (INR) · TTM

ORCHPHARMA.NS Revenue (INR) by quarter, trailing twelve months
Period	Revenue (INR)
27 Q1	9.43B
26 Q4	8.11B
26 Q3	8.11B
26 Q2	8.21B
26 Q1	8.5B
25 Q4	9.22B
25 Q3	9.02B
25 Q2	9.05B
25 Q1	8.81B
24 Q4	8.19B

Net Income (INR) · TTM

ORCHPHARMA.NS Net Income (INR) by quarter, trailing twelve months
Period	Net Income (INR)
27 Q1	86.67M
26 Q4	203.54M
26 Q3	188.68M
26 Q2	522.57M
26 Q1	852.17M
25 Q4	996.57M
25 Q3	1.11B
25 Q2	1.2B
25 Q1	1.12B
24 Q4	921.66M

Operating Income (INR) · TTM

ORCHPHARMA.NS Operating Income (INR) by quarter, trailing twelve months
Period	Operating Income (INR)
27 Q1	416.35M
26 Q4	441.05M
26 Q3	452.19M
26 Q2	761.43M
26 Q1	1.08B
25 Q4	1.27B
25 Q3	1.28B
25 Q2	1.37B
25 Q1	1.74B
24 Q4	1.64B

EBITDA · TTM

Cash Flows · TTM

EPS · TTM

Expenses · TTM

Cash & Debt · TTM

Debt ratios · TTM

Margins · TTM

Return on Capital · TTM

Shares Outstanding · TTM

Dividends (INR) · TTM

Employee Count

Book Value Per Share · TTM

Total Assets · TTM

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Orchid Pharma Limited

Video analysis: ORCHPHARMA.NS

News: ORCHPHARMA.NS

Similar companies